Skip to main content
HCPCS J0650 · Level II · Part B drug

J0650: levothyroxine sodium, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0650

Billing unit
10 MCG
Inj, levothyroxine nos 10mcg
ASP payment limit
$6.581
October 2026; +29.1% vs July 2026
Practitioner MUE
100
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0650 is the Level II code for Injection, levothyroxine sodium, not otherwise specified, 10 mcg, billed per 10 MCG. The Medicare Part B ASP payment limit for October 2026 is $6.581 per billing unit, up 29.1% from July 2026. The practitioner MUE allows up to 100 units per date of service (MAI 3), so a full 100-unit day is $658.10 at the current limit. Under OPPS it carries status indicator N. J0650 is billed in units of 10 MCG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names levothyroxine sodium: J0651 (the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0650); J0652 (the Hikma product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0650). The ASP crosswalk maps 18 NDCs to it, sold as Levothyroxine Sodium by Sagent Pharmaceuticals, Endo USA, Inc., FreseniUS Kabi USA, LLC. No current Billing and Coding Article lists J0650, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0650 at $6.581 per 10 MCG for October 2026, derived from manufacturer average sales price plus 6%, compared with $5.096 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0650
QuarterPayment limitPerCoinsurance
October 2026$6.58110 MCG20%
July 2026$5.09610 MCG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 18 NDCs from 6 labelers to J0650. Report the NDC in the claim's drug segment and bill the number of J0650 units that equals the quantity administered divided by 10 MCG; the last column gives units per full package.

NDCs that crosswalk to J0650
NDCDrug nameLabelerPackage sizeBilling units / package
25021-0468-10Levothyroxine SodiumSagent Pharmaceuticals1 × 110
25021-0469-10Levothyroxine SodiumSagent Pharmaceuticals1 × 120
25021-0470-10Levothyroxine SodiumSagent Pharmaceuticals1 × 150
42023-0201-01Levothyroxine SodiumEndo USA, Inc.1 × 110
42023-0202-01Levothyroxine SodiumEndo USA, Inc.1 × 120
42023-0203-01Levothyroxine SodiumEndo USA, Inc.1 × 150
63323-0647-10Levothyroxine SodiumFreseniUS Kabi USA, LLC1 × 120
63323-0648-10Levothyroxine SodiumFreseniUS Kabi USA, LLC1 × 150
63323-0649-07Levothyroxine SodiumFreseniUS Kabi USA, LLC5 × 110
63323-0649-16Levothyroxine SodiumFreseniUS Kabi USA, LLC1 × 110
63323-0649-94Levothyroxine SodiumFreseniUS Kabi USA, LLC5 × 110
70710-1833-01Levothyroxine SodiumZydus Pharmaceuticals (Usa) Inc.1 × 110
70710-1834-01Levothyroxine SodiumZydus Pharmaceuticals (Usa) Inc.1 × 120
70710-1835-01Levothyroxine SodiumZydus Pharmaceuticals (Usa) Inc.1 × 150
70860-0451-10Levothyroxine SodiumAthenex Pharmaceutical Division, LLC1 × 110
70860-0452-10Levothyroxine SodiumAthenex Pharmaceutical Division, LLC1 × 120
70860-0453-10Levothyroxine SodiumAthenex Pharmaceutical Division, LLC1 × 150
72266-0261-01Levothyroxine SodiumFosun Pharma USA Inc.1 × 110

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0650. For practitioners the limit is 100 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0650 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1003 Date of Service Edit: ClinicalCMS Policy
Facility outpatient hospital1003 Date of Service Edit: ClinicalCMS Policy
DME supplier1003 Date of Service Edit: ClinicalCMS Policy

MUE for J0650 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0650 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0650 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0650 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0650 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0650 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0650 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0650 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0650

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0650

What does HCPCS code J0650 describe?

J0650 is defined by CMS as "Injection, levothyroxine sodium, not otherwise specified, 10 mcg". Each billing unit represents 10 MCG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0650 a CPT code?

No. J0650 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as levothyroxine sodium; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0650 reports the drug itself in 10 mcg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0650 in October 2026?

The ASP-based payment limit is $6.581 per 10 MCG, with 20% beneficiary coinsurance. The July 2026 limit was $5.096. Commercial payers use their own fee schedules.

How many units of J0650 can be billed per day?

The practitioner Medically Unlikely Edit is 100 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "CMS Policy" as the rationale.

Which NDCs map to J0650?

The October 2026 ASP crosswalk lists 18 NDCs from 6 labelers: Levothyroxine Sodium (Sagent Pharmaceuticals); Levothyroxine Sodium (Endo USA, Inc.); Levothyroxine Sodium (FreseniUS Kabi USA, LLC); Levothyroxine Sodium (Zydus Pharmaceuticals (Usa) Inc.). For example NDC 25021-0468-10 (package size 1) equals 10 billing units of J0650.

Does J0650 have NCCI bundling edits?

No active practitioner PTP pairs list J0650 as a column-1 or column-2 code in the v323r0 release.

J0650 vs J0651: what is the difference?

Both are HCPCS Level II codes whose descriptor names levothyroxine sodium. What sets J0651 apart: the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0650. J0650 is billed per 10 mcg, limit $6.581, MUE 100; J0651 is billed per 10 mcg, limit $7.079, MUE 100. Report the code whose descriptor matches the product and setting in the record.

J0650 vs J0652: what is the difference?

Both are HCPCS Level II codes whose descriptor names levothyroxine sodium. What sets J0652 apart: the Hikma product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0650. J0650 is billed per 10 mcg, limit $6.581, MUE 100; J0652 is billed per 10 mcg, limit $6.315, MUE 100. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.